Skip to main content
. Author manuscript; available in PMC: 2021 Jul 21.
Published in final edited form as: Cerebrovasc Dis. 2020 Jul 21;49(4):419–426. doi: 10.1159/000509071

Table 1.

Baseline demographic and stroke risk factor characteristics for all stroke encounters (n = 1,601)

Entire Cohort (n = 1601) mRS 0–2 Favorable (n = 1074) mRS 3–6 Unfavorable (n = 527) P-value*
Age (years) (median [IQR], mean ± SD) 69 [58 – 78], 67.7 ± 13.4 67 [57 – 76], 65.6 ± 13.3 74 [63 – 82], 72.0 ± 12.7 < 0.0001
Females, n (%) 788 (49.2%) 502 (46.7%) 286 (54.3%) 0.0048
History of hypertension, n (%) 1264 (79.0%) 814 (75.8%) 450 (85.4%) < 0.0001
Diabetes mellitus type 2 621 (38.8%) 375 (34.9%) 246 (46.7%) < 0.0001
Dyslipidemia 1148 (71.7%) 758 (70.6%) 390 (74.0%) 0.1569
Current or former smoker, n (%) Missing, n 954 (60.7%) 29 648 (61.0%) 11 306 (60.1) 18 0.7827
Alcohol consumption, n (%) Missing, n 552 (36.5%) 89 407 (39.9%) 54 145 (29.5%) 35 < 0.0001
BMI ≥ 30, n (%) 755 (47.2%) 508 (47.3%) 247 (46.9%) 0.8732
Peripheral vascular disease, n (%) 161 (10.1%) 92 (8.6%) 69 (13.1%) 0.0060
Coronary artery disease, n (%) 477 (29.8%) 286 (26.6%) 191 (36.2%) < 0.0001
Atrial fibrillation, n (%) 355 (22.2%) 197 (18.3%) 158 (30.0%) < 0.0001
Carotid stenosis, n (%) 607 (37.9%) 408 (38.0%) 199 (37.8%) 0.9563
Intracranial atherosclerotic stenosis, n (%) 483 (30.2%) 318 (29.6%) 165 (31.3%) 0.4875
Anemia, n (%) 243 (15.2%) 120 (11.2%) 123 (23.3%) < 0.0001
Pro-coagulant coagulation disorder, n (%) 71 (4.4%) 42 (3.9%) 29 (5.5%) 0.1560
COPD, n (%) 188 (11.7%) 104 (9.7%) 84 (15.9%) 0.0004
Sleep apnea, n (%) 170 (10.6%) 102 (9.5%) 68 (12.9%) 0.0468
Family history of stroke, n (%) 358 (22.4%) 224 (20.9%) 134 (25.4%) 0.0412
Prior TIA, n (%) 191 (11.9%) 120 (11.2%) 71 (13.5%) 0.1897
Prior stroke (hemorrhagic or ischemic), n (%) 342 (21.4%) 200 (18.6%) 142 (26.9%) 0.0002
*

P-value: Continuous variables were compared using Wilcoxon rank-sum tests and categorical variables were compared using Fisher’s exact tests.